Biodar - Controlled Release Oral Dosage Forms

Biodar specializes in the development and manufacturing of controlled release oral dosage forms. This activity is taking place on a case by case basis. Biodar mainly specializes in microencapsulation of small crystals and particles and develops drug delivery systems based on multilayer microencapsulation, using fluidised bed film coating technology.

ORAL DRUG DELIVERY NEEDS

Biodar can provide solutions to most of the oral drug delivery needs by using its vast technological portfolio.

MATRIX TECHNOLOGIES

Several matrix technologies are available providing diffusion or erosion based release mechanisms of the active compounds. These techniques are applicable for both tablets and mini-tabs.

MICROENCAPSULATION

Microencapsulation is Biodar's main expertise. The company has over 20 years experience of microencapsulation, fluid bed based processes. In addition to laboratory scale fluid beds, Biodar is equipped with three production scale fluid beds therefore it can provide both development and production services.

FAST DISSOLVING

Biodar develops fast dissolving dosage forms mainly generics.

SOLUBILITY IMPROVEMENTS

By using in house methods and joint ventures with specialised companies, Biodar provides solubility improvement services.

ALGINATE BEADLETS

Alginate beadlets provide encapsulation protection and delivery options for hydrophobic drugs, which may come in oily phase. Currently Biodar produces such beadlets for nutraceutical purposes.

LIFE CYCLE MANAGEMENT OF ORAL DOSAGE FORMS

Biodar develops both generic and Added Value Generic dosage forms. In its portfolio, the company has its own products and products that are developed as joint ventures according to the customers' specific requirements. Biodar's portfolio of development candidates is mainly USA oriented.

In addition to generic development, Biodar is engaged in development of Added Value Generics. The company is focusing on providing solutions of combined solubility and delivery improvements. By using its microencapsulation, nanosizing capabilities, Biodar is able to create value for its partner's API's.